Which patients first? Planning the first clinical trial of xenotransplantation: A case for cardiac bridging

Xenotransplantation

Volumn 12, Issue 3, 2005, Pages 168-172

  Ibrahim, Zuhaib ^a,b   Ezzelarab, Mohamed ^a   Kormos, Robert ^a   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL TRIAL; EXPERIMENTAL MODEL; EXTRACORPOREAL OXYGENATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART ASSIST DEVICE; HEART FUNCTION; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; MEDICAL ETHICS; MORTALITY; NONHUMAN; NOTE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE; SWINE; TREATMENT PLANNING; XENOTRANSPLANTATION;

ANIMALS; HEART TRANSPLANTATION; HUMANS; PATIENT SELECTION; REOPERATION; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 17144431947     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2005.00218.x     Document Type: Note

References (30)

1. MCGREGOR CG, TEOTIA SS, BYRNE GW et al. Cardiac transplantation: progress toward the clinic. Transplantation 2004; 78: 1569.
2. KUWAKI K, KNOSALLA C, DOR FJMF et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-CD 154 monoclonal antibody-based regimen. Am J Transplant 2004; 4: 363.
3. KUWAKI K, TSENG Y-L, DOR FJMF et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29.
4. HERING BJ, AASHEIM TC, GRAHAM ML et al. Long-term (> 100 days) diabetes reversal in immunosuppressed nonhuman primate recipients of porcine islet xenografts. (Abstract no. 4). Am J Transplant 2004; 4(Suppl. 8): 160.
5. PASCHER A, SAUER IM, HAMMER C, GERLACH JC, NEUHAUS P. Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation 2003; 9: 309.
6. MIELES L, YE Y, LUO Y et al. Auxiliary liver allografting and xenografting in the nonhuman primate. Transplantation 1995; 59: 1670.
7. LUO Y, KOSANKE S, MIELES L et al. Comparative histopathology of hepatic allografts and xenografts in the nonhuman primate. Xenotransplantation 1998; 5: 197.
8. RAMIREZ P, CHAVEZ R, MAJADO M et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70: 989.
9. ROSE EA, MOSKOWITZ AJ, PACKER M et al. The REMATCH trial: rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg 1999; 67: 723.
10. ROSE EA, GELIJNS AC, MOSKOWITZ AJ et al. Long-term mechanical left ventricular assistance for end stage of heart failure. N Engl J Med 2001; 345: 1435.
11. FRAZIER OH, ROSE EA, OZ MC et al. Multicenter clinical evaluation of the HeartMate vented electric ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122: 1186.
12. COOPER DKC, KEOGH A, BRINK J et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: The present status of Xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 2000; 19: 1125.
13. US Department of Health and Human Services Food and Drug Administration, Center for Biologics Evaluation and Research. Draft Report of the Biological Response Modifiers Advisory Subcommittee on Xenotransplantation. Bethesda, MD. 1999.
14. MORGAN JA, JOHN R, RAO V et al. Bridging to transplant with the HeartMate left ventricular assist device: the Columbia-Presbyterian 12 year experience. J Thorac Cardiovasc Surg 2004; 127: 1309.
15. BIRKS EJ, TANSLEY PD, YACOUB MH et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004; 23: 964.
16. KAVARANA MN, PESSIN-MINISLEY MS, URTECHO J et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002; 73: 745.
17. MORGAN JA, JOHN R, LEE BJ, OZ MC, NAKA Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004; 77: 859.
18. GAMMIE JS, EDWARDS LB, GRITH BP, PIERSON RN III, TSAO L. Optimal time of cardiac transplantation after ventricular assist device implantation. J Thorac Cardiovasc Surg 2004; 127: 1789.
19. STILLER B, HETZER R, WANG Y et al. Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung transplant 2003; 22: 1201.
20. REINHARTZ O, STILLER B, EILERS R, FARRAR DJ. Current clinical status of pulsatile pediatric circulatory support. ASAIO J 2002; 48: 455.
21. SHUMWAY S. Transplant and ventricular assist devices: gender differences in application and implementation. J Thorac Cardiovasc Surg 2004; 127: 1253.
22. YE Y, LUO Y, KOBAYASHI T et al. Secondary organ allografting after a primary "bridging" xenotransplant. Transplantation 1995; 60: 19.
23. GOLLACKNER B, COOPER DKC. Determining whether allotransplantation can be safely carried out after a porcine organ bridge. Graft 2001; 4: 137.
24. BAERTSCHIGER RM, DOR FJMF, PRABARASUTH D, KUWAKI K, COOPER DKC. Absence of humoral and cellular alloreactivity in baboons sensitized to pig antigens. Xenotransplantation 2004; 11: 27.
25. KEY T, SCHUURMAN HJ, TAYLOR CJ. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate Xenotransplantation provoke antibodies that cross react with human leukocyte antigens? Xenotransplantation 2004; 11: 452.
26. JOHN R, LEITZ K, SCHUSTER M et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 2003; 125: 578.
27. MOSKOWITZ AJ, ROSE EA, GELIJNS AC. The cost of long-term LVAD implantation. Ann Thorac Surg 2002; 71(Suppl. 2): S195.
28. OZ MC, GELIJNS AC, MILLER L et al. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg 2003; 8: 577.
29. WEST LJ, POLLOCK-BARZIV SM, DIPCHAND AI et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344: 793.
30. FAN X, ANG A, POLLOCK-BARZIV SM et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10: 1227.